LeonardoC.ClavijoMD

Cardiology • Saint Helena, CA

Adult Congenital Heart Disease, Interventional Cardiology

Interventional Cardiology, Coastal Cardiology, Adventist Health St. Helena

Join to view full profile

Dr. Clavijo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Clavijo's full profile

Already have an account?

Office
6 Woodland Rd
Ste 304
Saint Helena, CA 94574
Phone+1 707-963-7200

Fax+1 805-782-8859

Education & Training

MedStar Health/Georgetown-Washington Hospital CenterFellowship, Interventional Cardiology, 2004 - 2005
MedStar Health/Georgetown-Washington Hospital CenterFellowship, Cardiovascular Disease, 2001 - 2004
MedStar Health/Georgetown-Washington Hospital CenterFellowship, Cardiovascular Disease, 2001 - 2003
University of Louisville School of MedicineResidency, Internal Medicine, 1996 - 1999
National University of ColombiaClass of 1992

Certifications & Licensure

CA State Medical License 2006 - 2025
DC State Medical License 2001 - 2006
VA State Medical License 2003 - 2006
KY State Medical License 1999 - 2002
IA State Medical License 1998 - 1999
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Top Doctors:LA Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012
Fellow (FACC) American College of Cardiology

Clinical Trials

Same Day Discharge After Coronary Stenting Trial Start of enrollment: 2009 Dec 01
Completed
Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study Start of enrollment: 2014 Feb 16
Completed
Phase 1, Phase 2
Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI) Start of enrollment: 2013 Jun 19
Completed
Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease Start of enrollment: 2017 Dec 14
Recruiting
Phase 4
Effect of Evolocumab in Patients With Critical Limb Ischemia (Evol-CLI) Start of enrollment: 2020 Feb 24
Recruiting
Phase 4
Join now to see all

Publications & Presentations

PubMed

The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial.
Matthew T Menard, Alik Farber, Gheorghe Doros, Katherine L McGinigle, Emiliano Chisci
Journal of Vascular Surgery. 2024-12-01
Effect of evolocumab in patients with chronic limb threatening ischemia (Evol-CLI study).
Ashwat S Dhillon, Jorge Caro, Jongkyu Choi, Jorge A Caro, Vincent Rowe
Cardiovascular Revascularization Medicine. 2024-11-28
4 citations
The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication ...
Leonardo C Clavijo, Jorge Caro, Jongkyu Choi, Jorge A Caro, Han Tun
Cardiovascular Revascularization Medicine. 2023-10-01

Journal Articles

Incidence and Treatment of Severe Primary Mitral Regurgitation in Contemporary Clinical Practice☆
Stephanie Wu, Audrey Chai, Anilkumar Mehra, Leonardo Clavijo, ScienceDirect

Press Mentions

BEST-CLI Shows Lower Incidence of Major Adverse Limb Events or Death with Surgical Bypass Versus Endovascular Treatment in CLTI Patients with Adequate GSVJanuary 23rd, 2023

Professional Memberships

American College of Cardiology - ACC
Member